985 related articles for article (PubMed ID: 33006093)
1. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.
Eslam M; Sarin SK; Wong VW; Fan JG; Kawaguchi T; Ahn SH; Zheng MH; Shiha G; Yilmaz Y; Gani R; Alam S; Dan YY; Kao JH; Hamid S; Cua IH; Chan WK; Payawal D; Tan SS; Tanwandee T; Adams LA; Kumar M; Omata M; George J
Hepatol Int; 2020 Dec; 14(6):889-919. PubMed ID: 33006093
[TBL] [Abstract][Full Text] [Related]
2. MAFLD, patient-centred care, and APASL.
Sarin SK; Eslam M; Fan JG; Lin HC; George J; Omata M
Hepatol Int; 2022 Oct; 16(5):1032-1034. PubMed ID: 36070122
[TBL] [Abstract][Full Text] [Related]
3. The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.
Fouad Y; Esmat G; Elwakil R; Zakaria S; Yosry A; Waked I; El-Razky M; Doss W; El-Serafy M; Mostafa E; Anees M; Sakr MA; AbdelAty N; Omar A; Zaki S; Al-Zahaby A; Mahfouz H; Abdalla M; Albendary M; Hamed AK; Gomaa A; Hasan A; Abdel-Baky S; El Sahhar M; Shiha G; Attia D; Saeed E; Kamal E; Bazeed S; Mehrez M; Abdelaleem S; Gaber Y; Abdallah M; Salama A; Tawab DA; Nafady S
Saudi J Gastroenterol; 2022; 28(1):3-20. PubMed ID: 35083973
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD;
J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
[TBL] [Abstract][Full Text] [Related]
5. From NAFLD in clinical practice to answers from guidelines.
Nascimbeni F; Pais R; Bellentani S; Day CP; Ratziu V; Loria P; Lonardo A
J Hepatol; 2013 Oct; 59(4):859-71. PubMed ID: 23751754
[TBL] [Abstract][Full Text] [Related]
6. Metabolic dysfunction associated fatty liver disease (MAFLD) and serum vitamin D concentration in South Korea.
Lee HK; Shin SR; Han AL
Asia Pac J Clin Nutr; 2022; 31(2):201-207. PubMed ID: 35766555
[TBL] [Abstract][Full Text] [Related]
7. MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.
Kawaguchi T; Tsutsumi T; Nakano D; Eslam M; George J; Torimura T
Clin Mol Hepatol; 2022 Apr; 28(2):150-163. PubMed ID: 34753279
[TBL] [Abstract][Full Text] [Related]
8. A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.
Ramírez-Mejía MM; Díaz-Orozco LE; Barranco-Fragoso B; Méndez-Sánchez N
Med Sci Monit; 2021 Aug; 27():e934134. PubMed ID: 34456329
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update.
Barchetta I; Cimini FA; Cavallo MG
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126575
[TBL] [Abstract][Full Text] [Related]
10. How should we manage patients with non-alcoholic fatty liver disease in 2007?
Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
[TBL] [Abstract][Full Text] [Related]
11. [Introduction to the APASL clinical guidelines on the management of metabolic-associated fatty liver disease].
Shi YW; Xiao QQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):915-917. PubMed ID: 33256275
[TBL] [Abstract][Full Text] [Related]
12. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.
Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z
Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166).
Fan JG; Jia JD; Li YM; Wang BY; Lu LG; Shi JP; Chan LY;
J Dig Dis; 2011 Feb; 12(1):38-44. PubMed ID: 21276207
[No Abstract] [Full Text] [Related]
14. MAFLD: Renovation of clinical practice and disease awareness of fatty liver.
Kawaguchi T; Tsutsumi T; Nakano D; Torimura T
Hepatol Res; 2022 May; 52(5):422-432. PubMed ID: 34472683
[TBL] [Abstract][Full Text] [Related]
15. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
Kim D; Konyn P; Sandhu KK; Dennis BB; Cheung AC; Ahmed A
J Hepatol; 2021 Dec; 75(6):1284-1291. PubMed ID: 34380057
[TBL] [Abstract][Full Text] [Related]
16. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.
Shiha G; Ibrahim A; Helmy A; Sarin SK; Omata M; Kumar A; Bernstien D; Maruyama H; Saraswat V; Chawla Y; Hamid S; Abbas Z; Bedossa P; Sakhuja P; Elmahatab M; Lim SG; Lesmana L; Sollano J; Jia JD; Abbas B; Omar A; Sharma B; Payawal D; Abdallah A; Serwah A; Hamed A; Elsayed A; AbdelMaqsod A; Hassanein T; Ihab A; GHaziuan H; Zein N; Kumar M
Hepatol Int; 2017 Jan; 11(1):1-30. PubMed ID: 27714681
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease guidelines: an Asian perspective.
Ishii H; Kajihara M
J Gastroenterol Hepatol; 2007 Jun; 22(6):769-70. PubMed ID: 17565626
[No Abstract] [Full Text] [Related]
18. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.
Loria P; Adinolfi LE; Bellentani S; Bugianesi E; Grieco A; Fargion S; Gasbarrini A; Loguercio C; Lonardo A; Marchesini G; Marra F; Persico M; Prati D; Baroni GS;
Dig Liver Dis; 2010 Apr; 42(4):272-82. PubMed ID: 20171943
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.
Niriella MA; Ediriweera DS; Kasturiratne A; De Silva ST; Dassanayaka AS; De Silva AP; Kato N; Pathmeswaran A; Wickramasinghe AR; de Silva HJ
PLoS One; 2021; 16(2):e0245762. PubMed ID: 33534815
[TBL] [Abstract][Full Text] [Related]
20. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease.
Chan WK; Tan SS; Chan SP; Lee YY; Tee HP; Mahadeva S; Goh KL; Ramli AS; Mustapha F; Kosai NR; Raja Ali RA
J Gastroenterol Hepatol; 2022 May; 37(5):795-811. PubMed ID: 35080048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
